# Senior Scientist, Discovery Oncology — Bristol Myers Squibb

- Location: San Diego - CA - US
- Posted pay: $132k–$159k/yr
- Posted: Nov 19, 2026
- Status: open (checked Nov 21, 2026)
- Apply (employer's site): https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/San-Diego---CA---US/Senior-Scientist--Discovery-Oncology_R1608301
- Employer record: https://visajobs.io/company/bristol-myers-squibb.md

## Sponsorship history
- Tier: Good history
- Occupation (SOC): Chemists (19-2031)
- …in the whole US: 59
- With this exact title: 0
- Median DOL prevailing wage, level I / II: $60k / $78k

## Description
At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.
The Protein Homeostasis Thematic Research Center (PH TRC) in BMS is one of the fundamental research and early development engines delivering therapeutics to patients. The group integrates discovery research through translational and early clinical development and focuses on numerous aspects of protein homeostasis including the ubiquitin-proteasome system, protein translation, and RNA processing and stability. This thematic focus allows the group to capitalize on the cutting-edge science that underpins the action of the company’s most advanced drugs. Not being bound by disease area or therapeutic modality creates a very dynamic, exciting, and creative environment that exploits excellent science in biology, biochemistry, structural biology, computational biology, and translational development.
Position Summary
The Discovery Oncology Department within the Protein Homeostasis Thematic Research Center (PH TRC) is focused on discovering and developing novel therapeutics by leveraging targeted protein degradation and other innovative approaches to modulate disease-relevant biology. We are seeking a highly motivated Senior Scientist with expertise in hematological malignancies, particularly Acute Myeloid Leukemia (AML), and experience in drug discovery research.
The successful candidate will work in a multidisciplinary environment to:
Drive the biological validation of novel therapeutic targets in hematological malignancies.
Develop and implement robust cellular and molecular assays to support drug discovery programs.
Design and execute mechanistic studies that advance our understanding of target biology, compound mechanism of action, mechanisms of resistance, biomarker strategies, and disease positioning.
Contribute to the development of translational hypotheses to support the progression of discovery programs toward clinical development.
This role requires a Senior Scientist capable of independently designing and executing experimental strategies, interpreting complex datasets, and influencing project team decisions. The successful candidate will work closely with chemistry, computational biology, bioinformatics, translational development, and other functional groups to advance innovative therapeutic programs towards the clinic.
Position Responsibilities
In the role as a Senior Scientist within the Discovery Oncology team, the ideal candidate will:
Independently design, execute, analyze, and interpret experiments to support target validation and drug discovery programs.
Develop and implement cellular, molecular, and biochemical assays to evaluate novel therapeutic hypotheses.
Design and conduct mechanistic studies in cancer cell biology, molecular biology, cellular biochemistry, and targeted protein degradation.
Utilize hematological disease models to investigate target biology, compound mechanism of action, resistance mechanisms, and biomarker strategies.
Collaborate closely with chemistry, bioinformatics, screening, and translational research teams to advance project objectives.
Integrate genomic, transcriptomic, proteomic, and functional datasets to generate actionable biological insights.
Lead scientific projects, initiatives and drive complex workstreams within multidisciplinary project teams.
Clearly communicate scientific findings through presentations, reports, publications, and project team discussions.
Mentor junior scientists and contribute to a collaborative and scientifically rigorous research environment.
Maintain accurate documentation and ensure delivery of high-quality data in a timely manner.
Experience
Basic Qualifications:
Bachelor’s Degree 7+ years of academic and / or industry experience
or
Master’s Degree 5+ years of academic and / or industry experience
or
Ph.D. or equivalent advanced degree in the Life Sciences 2+ of academic and / or industry experience
Preferred Qualifications:
PhD in Cancer Biology, Cell Biology, Hematology, or a related discipline with 3-6 years of relevant drug discovery experience, or MS/BS with equivalent industry experience and demonstrated scientific leadership in drug discovery.
Strong expertise in hematological malignancies, particularly Acute Myeloid Leukemia (AML); experience in other hematological malignancies is desirable.
Deep understanding of cancer biology, including disease genetics, transcriptional regulation, epigenetics, differentiation state biology, and mechanisms of therapeutic response and resistance.
Track record of applying disease biology insights to target validation, mechanism-of-action studies, and biomarker strategies for hematological malignancies.
Extensive hands-on experience with mammalian cell culture and molecular and cellular biology techniques, including flow cytometry, CRISPR/Cas9 gene editing, lentiviral approaches, western blotting, JESS, HiBiT assays, and functional cellular assays.
Experience designing and executing colony formation (CFU), proliferation, apoptosis, differentiation, and cell-cycle assays.
Demonstrated ability to independently drive scientific questions and translate findings into discoveries that advance drug discovery programs.
Experience identifying and evaluating pharmacodynamic biomarkers and translational strategies to support advancement of drug discovery programs.
Experience with targeted protein degradation, molecular glues, or E3 ligase biology is highly desirable.
Proficiency with scientific data analysis tools including GraphPad Prism, Flo

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
